MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$412,267K
(20.46%↑ Y/Y)
Unrealized gain on
marketable securities
$427K
(-41.59%↓ Y/Y)
Interest income
$29,195K
(-38.93%↓ Y/Y)
Net loss
-$412,694K
(20.49%↑ Y/Y)
Total other income,
net
$28,296K
(85.64%↑ Y/Y)
Change in fair value of
investments, net
-$899K
(97.24%↑ Y/Y)
Operating loss
-$440,990K
(17.46%↑ Y/Y)
Collaboration revenue
$67,671K
(16.92%↑ Y/Y)
Total operating
expenses
$508,661K
(-14.10%↓ Y/Y)
Research and development
$388,861K
(-16.61%↓ Y/Y)
General and
administrative
$119,800K
(-4.79%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Intellia Therapeutics, Inc. (NTLA)
Intellia Therapeutics, Inc. (NTLA)